A European Medicines Agency (EMA) committee said on Friday it has started a review of decongestant medicines for cold and flu that contain the ingredient pseudoephedrine following safety concerns.
The EMA said the review was due to reports of conditions affecting blood vessels in the brain in some patients who took pseudoephedrine-containing medicines.
Pseudoephedrine is a drug that is used alone or in combination with other medicines to treat a blocked nose due to cold, flu or allergy.
Makers of pseudoephedrine-containing drugs include Reckitt Benckiser, McNeil Products Ltd and Organon & Co.
(Reporting by Sriparna Roy in Bengaluru; editing by Shounak Dasgupta)
Topics Europe
Was this article valuable?
Here are more articles you may enjoy.
Insurance Mogul Lindberg Gets 12 Years for $2 Billion Fraud 
JPMorgan Banker Sues Ex-Colleague Over ‘Fabricated’ Sex Claims 
Acrisure to Cut 2,250 Employees, Citing Advances in Technology and AI 
Insurance Platform Corgi Valued at $2.6B in Funding Round 
